CD8A and COVID-19: However, the significant boosting of inducible SARS-CoV-2 S-specific CD8+ T cell responses selectively observed following vaccination of subjects experiencing moderate or severe COVID-19 suggests there may be a long-term immunological advantage associated with recovery from more severe COVID-19.